Signaling by insulin-like growth factor 1 in brain
Section snippets
Insulin and IGF1
Insulin and insulin-like growth factor (IGF) 1 are genetically related polypeptides that have similar tertiary structures and substantial amino acid identity. Insulin is synthesized predominantly in pancreatic beta cells from which its release is regulated by nutrient stimuli. IGF1 is made in great abundance by the liver where its synthesis is stimulated by pituitary growth hormone (GH). IGF1 is also synthesized locally in many tissues, including the brain, where GH does not regulate its
Insulin and IGF1 receptors
Like the cognate peptides, the insulin and IGF1 receptors (Fig. 1) demonstrate close structural homology and sequence identity (LeRoith, 1996). Insulin and IGF1 bind their cognate receptors with highest affinity, but cross-reactivity occurs at higher hormone concentrations. The insulin and IGF1 receptors are receptor tyrosine kinases (RTK) that, after ligand binding induced autophosphorylation, associate with insulin receptor substrate (IRS) adapter proteins. These IRS proteins bind to tyrosine
Sources of brain insulin and IGF1
Circulating insulin and IGF1 may influence hypothalamic neurons by interacting with receptors localized in the median eminence and circumventricular structures outside the blood–brain barrier. Both insulin and IGF1 receptors are expressed on brain capillaries, but IGF1 crosses the blood–brain barrier with significantly greater efficiency than insulin (Reinhardt and Bondy, 1994). After intra-carotid infusion of radiolabeled ligands, 3–4-fold more IGF1 is detected within isocortical parenchyma,
Regulation of brain IGF system expression
While it has been known for many years that IGF1 production in the liver and in some peripheral tissues is regulated by GH, there is virtually no understanding of factors regulating brain IGF1 expression. Nor is there any information on the regulation of brain IGF1 receptor or IGFBP expression. Because the insulin/IGF system is generally responsive to nutritional status Calikoglu et al., 2001, Thissen et al., 1994, we investigated the effects of modest caloric restriction and alteration of
Conclusions
Brain glucose utilization is usually viewed as a barometer of neural activity, but neurons also require glucose to support growth, repair and remodeling processes. We have reviewed evidence that IGF1 promotes brain anabolic activity resulting in increased neuronal survival, process growth and synaptogenesis during early postnatal development. It appears that IGF1 promotes neuronal growth and dendritogenesis by ‘insulin-like’ anabolic effects on glucose utilization and protein synthesis,
References (40)
Phosphorus assay in column chromatography
J. Biol. Chem.
(1959)- et al.
Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons
Neuron
(1995) - et al.
Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography
Brain Res.
(1988) - et al.
Mapping of brain insulin and insulin-like growth factor receptor gene expression by in situ hybridization
NeuroProtocols
(1992) - et al.
Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II
Neuroscience
(1992) - et al.
Glycogen, its transient occurrence in neurons of the rat CNS during normal postnatal development
Brain Res.
(1984) - et al.
Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues
Brain Res. Mol. Brain Res.
(1990) - et al.
Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal
J. Biol. Chem.
(2000) - et al.
Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration
Exp. Neurol.
(1994) - et al.
Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas
Neuroscience
(1986)
Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons
J. Biol. Chem.
Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
J. Biol. Chem.
Insulin-like growth factors in the response to cerebral ischemia
Mol. Cell. Neurosci.
Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II
Neuroscience
Insulin-like growth factor receptors and binding proteins
Bailliere's Clin. Endocrinol. Metab.
Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons
Neuroscience
Induction of IGF-1 mRNA expression following traumatic injury to the postnatal brain
Brain Res. Mol. Brain Res.
The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism
J. Biol. Chem.
The ketogenic diet: 1997
Adv. Pediatr.
Periventricular hypothalamic cells in rat brain contain insulin mRNA
Neuropeptides
Cited by (293)
Pro-neurogenic effects of Lilii Bulbus on hippocampal neurogenesis and memory
2023, Biomedicine and PharmacotherapyThe effects of lead exposure on the expression of IGF1R, IGFBP3, Aβ40, and Aβ42 in PC12 cells
2022, Journal of Trace Elements in Medicine and BiologySOD1-interacting proteins: Roles of aggregation cores and protein degradation systems
2021, Neuroscience ResearchHuman gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease
2021, Nutrition ResearchCitation Excerpt :Intriguingly, in APP/PS1 mice, SR79 treatment significantly increased IGF-1 expression in the cerebral cortex, compared to the vehicle-treated APP/PS1 mice (Fig. 8B). Moreover, AKT and GSK3β signaling, a key event in IGF-1 signaling [47], was upregulated by chronic SR79 oral treatment in APP/PS1 mice (Fig. 8D-F). Despite the increased expression of IGF-1 receptor mRNA in APP/PS1 mice, compared to non-Tg control mice, there was no evidence indicating changes in signaling, and therefore, the pathway was not upregulated (Fig. 8C-F).